Corcept Therapeutics Inc CORT

NAS: CORT | ISIN: US2183521028 30/01/2026

39,87 USD (-10,63%)

(-10,63%) 30/01/2026

Grafiek Corcept Therapeutics Inc

Grafiek Corcept Therapeutics Inc

1 dag1d -10,63%
1 week1w -13,74%
1 maand1m 14,08%
3 maanden3m -46,25%
6 maanden6m -44,45%
1 jaar1j -40,09%
5 jaar5j 37,29%

Corcept Therapeutics Inc in het nieuws

Toon enkel gratis nieuws

14 januari 2026 · Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman · Persbericht

6 januari 2026 · Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman · Persbericht

27 januari 2022 · Moore Kuehn, PLLC Encourages Investors of CORT and CACC to Contact Law Firm · Persbericht

15 maart 2021 · Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab (Keytruda®) in Patients with Adrenal Cancer with Cortisol Excess · Persbericht

23 februari 2021 · Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results · Persbericht

8 februari 2021 · Corcept Therapeutics Announces Fourth Quarter, Full-Year 2020 Preliminary Selected Financial Results and 2021 Revenue Guidance; Provides Corporate Update · Persbericht

1 februari 2021 · Corcept Therapeutics to Announce Preliminary Selected Financial Results, Provide Corporate Update and Host Conference Call · Persbericht

Profiel Corcept Therapeutics Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.corcept.com

Hoofdzetel: Menlo Park, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe